158 related articles for article (PubMed ID: 3987922)
41. Mucha-Habermann disease following estrogen-progesterone therapy.
Hollander A; Grots IA
Arch Dermatol; 1973 Mar; 107(3):465. PubMed ID: 4692137
[No Abstract] [Full Text] [Related]
42. Quantitation of hydroxyprogesterone caproate, medroxyprogesterone acetate, and progesterone by reversed-phase high-pressure liquid chromatography.
Das Gupta V
J Pharm Sci; 1982 Mar; 71(3):294-7. PubMed ID: 6461754
[TBL] [Abstract][Full Text] [Related]
43. The use of progestational agents for preterm birth: lessons from a mouse model.
Elovitz MA; Mrinalini C
Am J Obstet Gynecol; 2006 Oct; 195(4):1004-10. PubMed ID: 17000233
[TBL] [Abstract][Full Text] [Related]
44. Adverse health effects in children of women exposed in utero to diethylstilbestrol (DES).
Tournaire M; Epelboin S; Devouche E; Viot G; Le Bidois J; Cabau A; Dunbavand A; Levadou A
Therapie; 2016 Sep; 71(4):395-404. PubMed ID: 27203157
[TBL] [Abstract][Full Text] [Related]
45. Hormonal pregnancy tests and congenital malformation.
Gal I; Kirman B; Stern J
Nature; 1967 Oct; 216(5110):83. PubMed ID: 4860722
[No Abstract] [Full Text] [Related]
46. PREGNANEDIOL EXCRETION AND PLACENTAL INSUFFICIENCY.
RAWLINGS WJ
Fertil Steril; 1965; 16():323-36. PubMed ID: 14285363
[No Abstract] [Full Text] [Related]
47. [PROGESTERONE AND SYNTHETIC PROGESTATIVE AGENTS].
VOKAER R
Ann Endocrinol (Paris); 1964; 25():151-2. PubMed ID: 14163467
[No Abstract] [Full Text] [Related]
48. Cryptorchism and maternal estrogen exposure.
Beard CM; Melton LJ; O'Fallon WM; Noller KL; Benson RC
Am J Epidemiol; 1984 Nov; 120(5):707-16. PubMed ID: 6149686
[TBL] [Abstract][Full Text] [Related]
49. Human experiences related to adverse drug reactions to the fetus or neonate from some maternally administered drugs.
Shirkey HC
Adv Exp Med Biol; 1972; 27():17-30. PubMed ID: 4140679
[TBL] [Abstract][Full Text] [Related]
50. Cardiovascular birth defects and prenatal exposure to female sex hormones: importance of utilizing proper epidemiological methods and teratologic principles.
Brent RL
Teratology; 1994 Mar; 49(3):159-61. PubMed ID: 8059420
[No Abstract] [Full Text] [Related]
51. Medroxyprogesterone in in-vitro fertilization.
Barlow SM
Lancet; 1982 Dec; 2(8312):1408. PubMed ID: 6129501
[No Abstract] [Full Text] [Related]
52. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.
Winer N; Bretelle F; Senat MV; Bohec C; Deruelle P; Perrotin F; Connan L; Vayssière C; Langer B; Capelle M; Azimi S; Porcher R; Rozenberg P;
Am J Obstet Gynecol; 2015 Apr; 212(4):485.e1-485.e10. PubMed ID: 25448515
[TBL] [Abstract][Full Text] [Related]
53. Exposure to female hormone drugs during pregnancy: effect on malformations and cancer.
Hemminki E; Gissler M; Toukomaa H
Br J Cancer; 1999 Jun; 80(7):1092-7. PubMed ID: 10362122
[TBL] [Abstract][Full Text] [Related]
54. [Neonatal malformations and hormone therapy during pregnancy].
Pacilli L; Graffino W; Arrotta S
Minerva Ginecol; 1981; 33(7-8):659-65. PubMed ID: 7290498
[TBL] [Abstract][Full Text] [Related]
55. Impairment of male reproduction in adult rats exposed to hydroxyprogesterone caproate in utero.
Pushpalatha T; Ramachandra Reddy P; Sreenivasula Reddy P
Naturwissenschaften; 2004 May; 91(5):242-4. PubMed ID: 15146273
[TBL] [Abstract][Full Text] [Related]
56. Randomised trial of high doses of stilboestrol and ethisterone therapy in pregnancy: long-term follow-up of the children.
Beral V; Colwell L
J Epidemiol Community Health; 1981 Sep; 35(3):155-60. PubMed ID: 7035598
[TBL] [Abstract][Full Text] [Related]
57. [Lesions in children of hormone-treated mothers?].
Lauritzen C
Dtsch Med Wochenschr; 1977 Oct; 102(43):1569-70. PubMed ID: 913300
[No Abstract] [Full Text] [Related]
58. [Progestational hormones in the treatment of genital cancer].
Cella PL
Quad Clin Ostet Ginecol; 1969 Jun; 24(6):405-11. PubMed ID: 4099029
[No Abstract] [Full Text] [Related]
59. Embryotoxicity of sex steroidal hormones in nonhuman primates: II. Hydroxyprogesterone caproate, estradiol valerate.
Hendrickx AG; Korte R; Leuschner F; Neumann BW; Poggel A; Binkerd P; Prahalada S; Günzel P
Teratology; 1987 Feb; 35(1):129-36. PubMed ID: 3563931
[TBL] [Abstract][Full Text] [Related]
60. Reproductive effects of in utero exposure to estrogen and progestin drugs.
Hemminki E; Gissler M; Meriläinen J
Fertil Steril; 1999 Jun; 71(6):1092-8. PubMed ID: 10360916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
